Plain-English translation of NCT07511205 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is one of the first times this treatment has been tested in people.
This is an early-stage trial testing a new medication called designed to help with weight management. Researchers want to understand how the medication works in the body, how safe it is, and what the right dose should be. The study will enroll 104 healthy adults who are overweight or living with obesity.
Weight management is a significant health challenge, and current treatment options are limited. This trial is exploring whether this new medication could offer a safe and effective option for people working to manage their weight.
You likely qualify if…
You likely don't qualify if…
You would attend a screening visit lasting up to 5 weeks to confirm you are eligible. Then you would receive either the new medication or a placebo (a dummy treatment) as an injection under the skin or into a vein, depending on which group you join. The trial has two main parts: one testing single doses and another testing multiple doses given over time. Throughout the study, you would have follow-up visits where researchers check your blood work, vital signs, and how you are feeling to monitor safety.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
United States
United Kingdom